Tony Hawcock

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
There is considerable ongoing investment in the research and development of selective progesterone receptor (PR) modulators for the treatment of gynecological conditions such as endometriosis. Here,(More)
  • 1